Impact of the COVID-19 pandemic on the nephrology activity of hemodialysis started in an emergency context: a view from Morocco

Bentata, Y.

doi:10.1007/s40620-020-00947-2

Cited by 3 publications

(1 citation statement)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thus, several studies have been carried out in Morocco assessing the management strategies in healthcare environments including primary care, intensive care units, hemodialysis units, blood transfusion, and cancer centers [26][27][28][29][30][31][32][33][34][35][36]. Studies also included ethical and legal issues related to hydroxychloroquine treatment prescription for COVID-19 and COVID-19 disease recognition as work-related accident [14,37].…”

Section: Introductionmentioning

confidence: 99%

Prevalence and associated factors of COVID-19 among Moroccan physicians: A cross-sectional study

Baldi

Laghrissi²,

Marso³

et al. 2022

PLoS ONE

View full text Add to dashboard Cite

Background Coronavirus disease (COVID-19) has emerged and spread rapidly worldwide and established a global public health crisis in early 2020. The first Moroccan case was reported on March 2, 2020. Since then, healthcare workers (HCWs) played a major role in saving human lives threatened by COVID-19. This study aimed to assess the prevalence of COVID-19 infection among Moroccan physicians and to report associated risk factors prior vaccination campaign. Methods A cross-sectional study was carried out in the Fez-Meknes region of Morocco, 545 physicians’ data was collected using a self-reported online questionnaire. The data collection was done between December 1, 2020, and February 1, 2021. Results The prevalence of COVID-19 among physicians was 27.3%. The mean age of the confirmed COVID-19 group was 38.4±12.9 years old. There was no association between COVID-19 infection and preventive measures compliance by physicians and healthcare authorities in the workplace. However, multivariate analysis strengthened the following factors such as increased risk of COVID-19 infection within men ☯aOR:1.896; 95% IC 1.272–2.828; p = 0.002]; the presence of at least one comorbidity ☯aOR:2.268; 95%IC 1.414–3.637; p = 0.001]; and working at a university or military hospitals ☯aOR:2.578; 95%IC 1.667–3.989; p = 0.001]. Conclusion This study allows comparing COVID-19 prevalence among healthcare workers before and after vaccination programs. This should support better preparation strategy for any future pandemics with appropriate and increased awareness for men, carrying comorbidity, and working environment with high COVID-19 disease management.

show abstract

Section: Introductionmentioning

confidence: 99%

Prevalence and associated factors of COVID-19 among Moroccan physicians: A cross-sectional study

Baldi

Laghrissi²,

Marso³

et al. 2022

PLoS ONE

View full text Add to dashboard Cite

show abstract

Severe hypercalcemia requiring acute hemodialysis: A retrospective cohort study with increased incidence during the Covid-19 pandemic

Bentata

Benabdelhak

Haddiya

et al. 2022

The American Journal of Emergency Medicine

View full text Add to dashboard Cite

End-stage kidney disease patients with severe coronavirus disease: clinical characteristics, biological data, and mortality in nephrology unit, short communication

Ramdani,

Oujidi,

Elmaghraoui

et al. 2023

Annals of Medicine &Amp; Surgery

View full text Add to dashboard Cite

Introduction: Patients suffering from end-stage kidney disease (ESKD) are particularly vulnerable to SARS-CoV-2 infection, and their risk of death is higher than for the general population. The objective was to determine the epidemiologic profile at admission and mortality among patients presenting EKSD with severe coronavirus disease (COVID-19). Methods: A retrospective study was conducted in the Nephrology unit between October 2020 and February 2022. Were included all adult patients who presented ESKD on dialysis, or not on dialysis with an estimated glomerular filtration rate less than or equal to 15 ml/min/1.73 m2 and presenting a confirmed COVID-19. Patients with ESKD who were immediately admitted to the ICU were excluded. Results: Sixty-five patients’ data were collected. The mean age was 58.9 ±16.7 years and 60% were males. Hypertension arterial and diabetes observed in 75% and 56.3% of cases, respectively. 52.3% were on haemodialysis, 4.6% were on peritoneal dialysis and 43.1% not were on dialysis. 94% of the patients were symptomatic of COVID-19, dominated by dyspnoea (87.5%), cough (65.6%), and fever (58.5%). More than half of patients (58.5%) showed signs of gravity and 62% required oxygen therapy. According to thoracic scan, 72.3% were classified COVID-19 Raw Data System 5 and 6. Most patients had severe anaemia (58.5%), lymphopenia (81.3%), and high levels of C-reactive protein (54%), D-Dimer (93.6%) and ferritin (91.2%). 38.5% of patients presented complications of whom 60% were transferred to ICU. Mortality was observed in 8% of cases. Conclusion: Rigorous monitoring is necessary for patients in ESKD, particularly those with comorbidities, to reduce the risk of severe form of COVID-19.

show abstract

Impact of the COVID-19 pandemic on the nephrology activity of hemodialysis started in an emergency context: a view from Morocco

Cited by 3 publications

References 4 publications

Prevalence and associated factors of COVID-19 among Moroccan physicians: A cross-sectional study

Prevalence and associated factors of COVID-19 among Moroccan physicians: A cross-sectional study

Severe hypercalcemia requiring acute hemodialysis: A retrospective cohort study with increased incidence during the Covid-19 pandemic

End-stage kidney disease patients with severe coronavirus disease: clinical characteristics, biological data, and mortality in nephrology unit, short communication

Contact Info

Product

Resources

About